Teva taxing the public's patience? The public has been growling over the sweetheart tax rates paid by multinationals. In 2012, Teva Pharmaceutical Industries set aside just $5 million for tax from its profits made in Israel, following large accounting charges, notably a $670 million provision for a patent challenge over the drug Protonix. Actual tax paid was higher, though the drug...